AMC [AMC ENTERTAINMENT] 8-K: AMC ENTERTAINMENT HOLDINGS, INC. ANNOUNCES FOURTH QUARTER AND

[AMC ENTERTAINMENT HOLDINGS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2013 RESULTS Mr. Lopez continued, “With the extremely robust AMC Stubs membership loyalty program as an anchor, we delivered record revenues and our revenue growth outpaced the domestic box office performance. Furthermore, with the completion of our IPO and the subsequent refinancing of a significant portion of our outstanding debt,] []

By | 2016-03-26T21:13:51+00:00 February 25th, 2014|Categories: AMC, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

EVK [Ever-Glory International] 8-K: (Original Filing)

[Ever-Glory Received a Warning Letter from NYSE Regulations Regarding Failure to Obtain Shareholders Approval on Issuance of Certain Compensation Shares NANJING, China, February 21, 2014 /PRNewswire/ -- Ever-Glory International Group, Inc. (the "Company" or "Ever-Glory") (NYSE MKT: EVK), a leading apparel supply chain manager and retailer based in China, today announced that, on February 14, 2014, it received a warning] [FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): February 21, 2014 (February 14, 2014) EVER-GLORY INTERNATIONAL GROUP, INC. Florida 000-28806 65-0420146 (State or other jurisdiction of incorporation) (Commission File No.) (IRS Employer Identification No.) Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, Peoples Republic of China (8625) 5209-6889 o ¨ ¨ ¨]

By | 2016-03-28T11:18:19+00:00 February 21st, 2014|Categories: Chinese Stocks, EVK, SEC Original|Tags: , , , , , |0 Comments
Read More

EVK [Ever-Glory International] 8-K: Ever-Glory Received a Warning Letter from NYSE Regulations

[Ever-Glory Received a Warning Letter from NYSE Regulations Regarding Failure to Obtain Shareholders Approval on Issuance of Certain Compensation Shares NANJING, China, February 21, 2014 /PRNewswire/ -- Ever-Glory International Group, Inc. (the "Company" or "Ever-Glory") (NYSE MKT: EVK), a leading apparel supply chain manager and retailer based in China, today announced that, on February 14, 2014, it received a warning] [FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): February 21, 2014 (February 14, 2014) EVER-GLORY INTERNATIONAL GROUP, INC. Florida 000-28806 65-0420146 (State or other jurisdiction of incorporation) (Commission File No.) (IRS Employer Identification No.) Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, Peoples Republic of China (8625) 5209-6889 o ¨ ¨ ¨]

By | 2016-03-28T11:19:25+00:00 February 21st, 2014|Categories: Chinese Stocks, EVK, Webplus ver|Tags: , , , , , |0 Comments
Read More

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[TPI Reports Second Quarter Fiscal Year 2014 Financial Results CHENGDU, China, February 14, 2014 -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the second quarter of fiscal year 2014. Second Quarter Fiscal 2014 Ended December 31,] [Tianyin Pharmaceutical Inc. Second Quarter Fiscal Year 2014 Financial Results Conference Call February 14, 2014 Operator I will now turn the presentation over to James Tong, CFO of the Company. Dr. Tong: Second Quarter of Fiscal 2014 Ended December 31, 2013 Financial Highlights: ● Revenue was $13.9 million versus $17.6 million in the second quarter FY 2013, a decrease of] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K Current Report February 14, 2014 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction Identification No.) (IRS Employer of incorporation) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By | 2016-03-19T15:53:50+00:00 February 21st, 2014|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments
Read More

TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI Reports Second Quarter Fiscal Year 2014 Financial

[TPI Reports Second Quarter Fiscal Year 2014 Financial Results CHENGDU, China, February 14, 2014 -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the second quarter of fiscal year 2014. Second Quarter Fiscal 2014 Ended December 31,] [Tianyin Pharmaceutical Inc. Second Quarter Fiscal Year 2014 Financial Results Conference Call February 14, 2014 Operator I will now turn the presentation over to James Tong, CFO of the Company. Dr. Tong: Second Quarter of Fiscal 2014 Ended December 31, 2013 Financial Highlights: ● Revenue was $13.9 million versus $17.6 million in the second quarter FY 2013, a decrease of] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K Current Report February 14, 2014 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction Identification No.) (IRS Employer of incorporation) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By | 2016-03-19T15:55:05+00:00 February 21st, 2014|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Read More

MONT [MONTAGE TECHNOLOGY] 8-K: (Original Filing)

[Montage Technology Reports Fourth Quarter and Fiscal 2013 Financial Results Fourth Quarter Revenue Increases 17.9% Sequentially and 49.5% Year-Over-Year to $35.4 Million; Gross Margin was 62.4% and Operating Margin 25.1% SHANGHAI, China – February 20, 2014 Fourth Quarter 2013 Highlights: • Attained record revenue of $35.4 million, an increase of 17.9 percent sequentially and 49.5 percent year-over-year; • Reported 62.4] [Item 2.02 Results of Operations and Financial Condition Item 9.01 99.1]

By | 2016-03-20T02:09:09+00:00 February 20th, 2014|Categories: Chinese Stocks, MONT, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Inc. Expects 2013 Yearly Revenue Growth above 20% with Break Even Operating Results as Compared With Last Year’s USD$21.8 million loss from operations XIANYANG, China, February 20, 2014 –Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 20, 2014 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]

By | 2016-03-28T18:42:24+00:00 February 20th, 2014|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

MONT [MONTAGE TECHNOLOGY] 8-K: Montage Technology Reports Fourth Quarter and Fiscal 2013

[Montage Technology Reports Fourth Quarter and Fiscal 2013 Financial Results Fourth Quarter Revenue Increases 17.9% Sequentially and 49.5% Year-Over-Year to $35.4 Million; Gross Margin was 62.4% and Operating Margin 25.1% SHANGHAI, China – February 20, 2014 Fourth Quarter 2013 Highlights: • Attained record revenue of $35.4 million, an increase of 17.9 percent sequentially and 49.5 percent year-over-year; • Reported 62.4] [Item 2.02 Results of Operations and Financial Condition Item 9.01 99.1]

By | 2016-03-20T02:10:29+00:00 February 20th, 2014|Categories: Chinese Stocks, MONT, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar